Search

Your search keyword '"Gómez García, Encarna B."' showing total 139 results

Search Constraints

Start Over You searched for: Author "Gómez García, Encarna B." Remove constraint Author: "Gómez García, Encarna B."
139 results on '"Gómez García, Encarna B."'

Search Results

2. Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers

3. Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers

4. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome–Associated Colorectal Carcinomas

6. Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers

7. Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

8. Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy

9. Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

10. Figure 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

11. Figure 3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

12. Figure 6 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

13. Table S2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

14. Data from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

15. Figure 4 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

16. Supplementary Methods 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

17. Figure 2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

18. Figure 5 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

19. Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

20. Supplementary Figures 1 - 3 from MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

21. Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

22. ENIGMA CHEK2gether Project:A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

23. Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

24. Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

25. Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome

26. Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients

28. Role of germline aberrations affecting,andin gastric cancer susceptibility

29. Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group

30. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility

31. Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

32. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

33. Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers

34. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients

35. Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers

36. Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

37. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients

38. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients

39. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1

40. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1

41. Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers

42. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

43. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1

44. Breast cancer risk and 6q22.33 : combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

45. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

46. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

47. Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome

48. MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

49. Genetic Testing in Li-Fraumeni Syndrome: Uptake and Psychosocial Consequences

50. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history

Catalog

Books, media, physical & digital resources